Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat

European Urology

Volumn 56, Issue 1, 2009, Pages 134-141

  Silva, João ^a   Pinto, Rui ^a   Carvallho, Tiago ^a   Coelho, Ana ^b   Avelino, Antonio ^b,c   Dinis, Paulo ^a,b,c   Cruz, Francisco ^a,b,c  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Botulinum toxin; Parasympathetic nerves; Prostate; Sensory nerves; Sympathetic nerves

Indexed keywords

BETHANECHOL; BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; PHENYLEPHRINE; TYROSINE 3 MONOOXYGENASE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL STUDY; MALE; NICK END LABELING; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE ATROPHY; PROSTATE DISEASE; PROSTATE HYPERTROPHY; RAT; WISTAR ALBINO GLAXO RAT;

ANIMALS; ATROPHY; BETHANECHOL; BOTULINUM TOXIN TYPE A; DRUG AGONISM; INJECTIONS; MALE; NEUROTOXINS; ORGAN SIZE; PARASYMPATHOMIMETICS; PHENYLEPHRINE; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 67349094553     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.07.003     Document Type: Article

References (29)

1. Cruz F., and Dinis P. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourol Urodyn 26 Suppl 6 (2007) 920-927
2. Maria G., Brisinda G., Civello I.M., Bentivoglio A.R., Sganga G., and Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 62 (2003) 259-264
3. Kuo H.C. Prostate botulinum A toxin injection-an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 65 (2005) 670-674
4. Silva J., Silva C., Saraiva L., et al. Intraprostatic botulinum toxin type A injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption. Eur Urol 53 (2008) 153-159
5. Chuang Y.C., Chiang P.H., Huang C.C., Yoshimura N., and Chancellor M.B. Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66 (2005) 775-779
6. Doggweiler R., Zermann D.H., Ishigooka M., and Schmidt R.A. Botox-induced prostatic involution. Prostate 37 (1998) 44-50
7. Lin A.T.L., Yang A.H., and Chen K.-K. Effects of botulinum toxin A on the contractile function of dog prostate. Eur Urol 52 (2007) 582-589
8. Dolly J.O., and Aoki K.R. The structure and mode of action of different botulinum toxins. Eur J Neurol 13 Suppl 4 (2006) 1-9
9. Chuang Y.C., Huang C.C., Kang H.Y., et al. Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol 175 (2006) 158-163
10. Chuang Y.C., and Chancellor M.B. The application of botulinum toxin in the prostate. J Urol 176 (2006) 2375-2382
11. Smith C.P., Franks M.E., McNeil B.K., et al. Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 169 (2003) 1896-1900
12. Jones O.M., Moore J.A., Brading A.F., and Mortensen N.J. Botulinum toxin injection inhibits myogenic tone and sympathetic nerve function in the porcine internal anal sphincter. Colorectal Dis 5 (2003) 552-557
13. Duggan M.J., Quinn C.P., Chaddock J.A., et al. Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a clostridium botulinum toxin A endopeptidase fragment and erythrina cristagalli lectin. Biol Chem 277 (2002) 34846-34852
14. Rapp D.E., Turk K.W., Bales G.T., and Cook S.P. Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol 175 (2006) 1138-1142
15. Witte L.P.W., Chapple C.R., de la Rosette JJMCH, and Michel M.C. Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol 54 (2008) 326-334
16. Pennefather J.N., Lau W.A., Mitchelson F., and Ventura S. The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies. Auton Pharmacol 20 (2000) 193-206
17. Dinis P., Charrua A., Avelino A., et al. The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate. Eur Urol 48 (2005) 162-167
18. Ramien M., Ruocco I., Cuello A.C., St. Louis M., and Ribeiro-da-Silva A. Parasympathetic nerve fibers invade the upper dermis following sensory denervation of the rat lower lip skin. J Comp Neurol 469 (2004) 83-95
19. McVary K.T., Razzaq A., Lee C., Venegas M.F., Rademaker A., and McKenna K.E. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 51 (1994) 99-107
20. Anglin I.E., Glassman D.T., and Kyprianou N. Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis 5 (2002) 88-95
21. McConnell J.D., Roehrborn C.G., Bautista O.M., et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349 (2003) 2387-2398
22. Yono M., Foster Jr. H.E., Shin D., Takahashi W., Pouresmail M., and Latifpour J. Doxazosin-induced up-regulation of alpha 1A-adrenoceptor mRNA in the rat lower urinary tract. Can J Physiol Pharmacol 82 (2004) 872-878
23. Apostolidis A., Popat R., Yiangou Y., et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174 (2005) 977-982
24. Schaible H.G., Del Rosso A., and Matucci-Cerinic M. Neurogenic aspects of inflammation. Rheum Dis Clin North Am 31 (2005) 77-101
25. Di Silverio F., Gentile V., and De Matteis A. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 43 (2003) 164-175
26. Chuang Y.-C., Yoshimura N., and Wu M. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur Urol 51 (2007) 1119-1127
27. Matityahou A., Rosenzweig N., and Golomb E. Rapid proliferation of prostatic epithelial cells in spontaneously hypertensive rats: a model of spontaneous hypertension and prostate hyperplasia. J Androl 24 (2003) 263-269
28. Ullrich P.M., Lutgendorf S.K., and Kreder K.J. Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia. Urology 70 (2007) 487-491
29. Dong M., Yeh F., Tepp W.H., et al. SV2 is the protein receptor for botulinum neurotoxin A. Science 312 (2006) 592-596